COST

922.22

-0.08%↓

PG

146.7

+0.49%↑

KO

70.59

+2.22%↑

PM

153.11

+2.22%↑

PEP

143

+1.05%↑

COST

922.22

-0.08%↓

PG

146.7

+0.49%↑

KO

70.59

+2.22%↑

PM

153.11

+2.22%↑

PEP

143

+1.05%↑

COST

922.22

-0.08%↓

PG

146.7

+0.49%↑

KO

70.59

+2.22%↑

PM

153.11

+2.22%↑

PEP

143

+1.05%↑

COST

922.22

-0.08%↓

PG

146.7

+0.49%↑

KO

70.59

+2.22%↑

PM

153.11

+2.22%↑

PEP

143

+1.05%↑

COST

922.22

-0.08%↓

PG

146.7

+0.49%↑

KO

70.59

+2.22%↑

PM

153.11

+2.22%↑

PEP

143

+1.05%↑

Search

USANA Health Sciences Inc

Uždarymo kaina

19.02 -0.47

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

18.75

Max

19.35

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1.2M

10M

Pardavimai

-22M

214M

P/E

Sektoriaus vid.

11.806

29.307

Pelnas, tenkantis vienai akcijai

-0.15

Pelno marža

4.428

Darbuotojai

1,700

EBITDA

-17M

11M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+103.55% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

6.6M

388M

Ankstesnė atidarymo kaina

19.49

Ankstesnė uždarymo kaina

19.02

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-07 21:06; UTC

Pagrindinės rinkos jėgos

JBS Down After Trump Calls for Probe into Meat-Packing Companies

2025-11-07 22:36; UTC

Uždarbis

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

2025-11-07 22:22; UTC

Uždarbis

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q Rev $2.95B >CSU.T

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q Net $210M >CSU.T

2025-11-07 22:03; UTC

Uždarbis

Constellation Software 3Q EPS $9.89 >CSU.T

2025-11-07 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-11-07 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-11-07 20:59; UTC

Uždarbis

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

2025-11-07 20:26; UTC

Rinkos pokalbiai

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

2025-11-07 20:22; UTC

Uždarbis

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

2025-11-07 20:04; UTC

Rinkos pokalbiai

Oil Futures Close Choppy Week With Losses -- Market Talk

2025-11-07 19:34; UTC

Rinkos pokalbiai

Gold Posts Small Gain for Week -- Market Talk

2025-11-07 19:31; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

2025-11-07 19:17; UTC

Uždarbis

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

2025-11-07 19:09; UTC

Uždarbis

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

2025-11-07 19:08; UTC

Uždarbis

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

2025-11-07 18:31; UTC

Rinkos pokalbiai

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

2025-11-07 17:27; UTC

Rinkos pokalbiai

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-11-07 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-11-07 17:17; UTC

Įsigijimai, susijungimai, perėmimai

Satair Expects to Complete Purchase in Early 2026

2025-11-07 17:17; UTC

Įsigijimai, susijungimai, perėmimai

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

2025-11-07 17:15; UTC

Įsigijimai, susijungimai, perėmimai

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

2025-11-07 17:09; UTC

Rinkos pokalbiai

PENN Is Falling Further Behind Competitors -- Market Talk

2025-11-07 16:49; UTC

Rinkos pokalbiai

Losing ESPN Partnership Will Hurt PENN -- Market Talk

2025-11-07 16:24; UTC

Rinkos pokalbiai

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

2025-11-07 16:17; UTC

Rinkos pokalbiai

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

103.55% į viršų

12 mėnesių prognozė

Vidutinis 39 USD  103.55%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat